can tirzepatide cause restless legs Mounjaro and Legs: Causes, Management and When to Seek Help Restless Leg Syndrome in Venice,

A dedicated cardiovascular outcomes trial (SURPASS-CVOT) was enrolling when this article was prepared, and the specific contribution of GIP receptor signaling in adipose tissue and the central nervous system remains under basic-pharmacology investigation

[4] Ultimately, the choice of GLP-1 agonist should be a collaborative decision between the patient and their healthcare provider, taking into account individual factors, treatment goals, and potential risks and benefits

What Some Studies Show So Far Research into GLP-1 medications in adults is abundant, but research on adolescents is still limited

Although no details were given, market observers suspect that the additional medical indication will be directed towards obesity

Lipotropic compounds help the body process and transport fats more efficiently , which can support patients who are working toward weight management and metabolic health

Karger, 189-201, 2000